http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 01 Jul 2024 17:46:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Press+Releases/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906 http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html <p> FLOWER MOUND, Texas--(BUSINESS WIRE)-- <b><i><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fus.mannatech.com%2F&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=Mannatech%2C+Incorporated&amp;index=1&amp;md5=79d0eaa1d5d2760829461206af28fa59" shape="rect">Mannatech, Incorporated</a></i></b> <i>(NASDAQ: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=54089827&amp;newsitemid=20240701741923&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=b4fafaf49248e34308cfcbdea26bea93" shape="rect">MTEX</a></i>) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. </p><p> James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and http://www.streetinsider.com/Business+Wire/Mannatech+Announces+Appointment+of+James+Clavijo+as+Chief+Financial+Officer/23423024.html Mon, 01 Jul 2024 17:46:00 -0400 A.00477796 A.12763360 AEZS GTHP LVGN MTEX O.00172307 O.00177454 O.00673999 O.20319167 O.31940906